NEWS
Mesoblast rattles tin for at least $37m with Bell Potter

MELBOURNE: Mesoblast, the local biotech developing treatments for cardiovascular disease and back pain, ... read more
MELBOURNE: Mesoblast, the local biotech developing treatments for cardiovascular disease and back pain, ... read more